Prevent BLEEDing Act of 2022

Bill 117 HR 7850, also known as the Prevent BLEEDing Act of 2022, is a piece of legislation introduced in the US Congress with the aim of addressing and preventing bleeding disorders in individuals. The bill focuses on improving access to care, treatment, and support for those affected by bleeding disorders, such as hemophilia and von Willebrand disease.

Key provisions of the Prevent BLEEDing Act include:

1. Establishing a national program to provide education and outreach on bleeding disorders, including information on diagnosis, treatment options, and support services. 2. Increasing funding for research into bleeding disorders, with a focus on developing new treatments and improving patient outcomes. 3. Enhancing coordination between federal agencies, healthcare providers, and patient advocacy organizations to ensure that individuals with bleeding disorders receive comprehensive and timely care. 4. Expanding access to affordable and effective treatments for bleeding disorders, including clotting factor products and other medications. 5. Improving data collection and reporting on bleeding disorders to better understand the prevalence and impact of these conditions in the US population. Overall, the Prevent BLEEDing Act aims to improve the quality of life for individuals with bleeding disorders by increasing awareness, access to care, and research funding. The bill has received bipartisan support in Congress and is currently under consideration for passage.